{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "G",
  "name": "Genpact Limited",
  "url": "https://orbyd.app/dossiers/G/",
  "json_url": "https://orbyd.app/dossiers/G.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "Agentic-operations pivot is compounding in the segment data — Advanced Technology Solutions +24.1% to $363M, FY guide raised to at least 25% on 2026-08-06 — but the 73% legacy book grew 1.9% and caps total growth near 7%. Shares fell ~3% on the beat to $34.29, 28.5% under the 52-week high; the re-rate has not started and the next binary is the Q3 print in early November.",
  "invalidation_trigger": "A weekly close below $32 erases the entire three-month advance and the shelf built around the 2026-08-06 Q2 release; confirmed fundamentally if Core Business Services prints an outright YoY decline at the Q3 report (~2026-11-05, est.) with ATS growth under 20%.",
  "catalyst_date": null,
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "ai-enterprise-software",
    "ai-datacenter-infrastructure",
    "cyclical-industrials"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Bermuda-incorporated, NYSE-listed, delivery footprint weighted to India — INR/USD and Indian tax changes hit reported margin directly.",
    "Calendar-year fiscal reporting; Q2 ended 2026-06-30 and results were released after the close on 2026-08-06.",
    "Current segment disclosure is Advanced Technology Solutions / Core Business Services; older filings use different segment labels, so multi-year segment series are not like-for-like.",
    "Pays a quarterly dividend ($0.1875 declared 2026-07-16) and repurchases stock, so share count and per-share figures shift quarter to quarter."
  ],
  "body_markdown": "## Current Thesis\nThe leg on offer is a re-rate: a headcount-priced services company being repriced as a seller of the technology that was supposed to displace it. Q2 2026 (released 2026-08-06) made the split explicit — Advanced Technology Solutions $363M, +24.1% YoY, 27% of net revenue; Core Business Services $980M, +1.9% YoY, the other 73%. Management raised full-year ATS growth guidance to at least 25% (from mid-teens) while holding total net revenue growth at \"at least 7%,\" because roughly two points of full-year revenue are being removed by exiting non-strategic work, concentrated in the second half. Shares closed $34.29 on 2026-08-07, 28.5% below the 52-week high of $47.99, after trading down about 3.2% intraday on the reaction session to a beat. The operating pivot is compounding; the multiple has not moved for it.\n\n## Bull Case\n- ATS revenue $363M in Q2 2026, +24.1% YoY, and full-year ATS guidance lifted to at least 25% growth on the 2026-08-06 call — a guidance raise on the segment that carries the narrative.\n- Agentic solutions on track to book over $1B of total contract value in 2026, described on the Q2 call as roughly five times the 2025 figure; agentic work was close to 40% of Q2 bookings and more than half of cumulative awarded contract value came from new clients.\n- Large-deal count 12 year-to-date versus 6 in the prior-year period, with 6 signed in Q2 against 3 a year earlier (Q2 call, 2026-08-06).\n- Non-FTE revenue passed 50% of total for the first time. That decouples the revenue line from billable headcount, which is the structural answer to the argument that agents deflate seat-based services.\n- Gross margin 36.5% in Q2, up roughly 60bps YoY and the thirteenth consecutive quarter of expansion; full-year guidance is ~36.5% gross and ~17.7% adjusted operating margin, up ~25bps.\n- Adjusted EPS $1.00, +13.6% YoY on 7.1% revenue growth — operating leverage, not a buyback artifact alone. ~1.6M shares repurchased for ~$50M in Q2 plus $32M of dividends.\n- A $34.29 close against full-year adjusted EPS guidance of more than $4.09 is a low multiple relative to the services complex; the quarterly dividend was raised to $0.1875 on 2026-07-16.\n\n## Bear Case\n- The raise was cosmetic at the total-company line. FY2026 adjusted EPS guided to \"more than $4.09\" against a $4.07 consensus and revenue \"more than $5.436B\" against $5.435B — inside the rounding.\n- Q3 guidance sits at or under consensus on every line: revenue $1.369–1.382B vs $1.382B, adjusted EPS $1.04–1.05 vs $1.05, GAAP EPS $0.89–0.90 vs $0.91.\n- Core Business Services grew 1.9% in Q2 and was guided flat-to-slightly-down for Q3. Seventy-three percent of the book at zero growth caps what a 27% segment growing 25% can do to the consolidated line.\n- The market sold the print. Shares fell roughly 3% on 2026-08-07 even as four of five brokers moved targets higher the same day.\n- Cash conversion is back-half dependent: six-month operating cash flow of $48.9M against $50M of Q2 repurchases and $32M of Q2 dividends. Cash $517.4M versus total debt $1.18B at 2026-06-30.\n- If clients capture the AI savings through price, the growth shows up as flat revenue and compressed margin. Thirteen quarters of gross-margin expansion is the counter-evidence so far; one reversal ends it.\n\n## Setup & Price Structure\n- Basis: close $34.29 on 2026-08-07; 52-week high $47.99 (-28.5%); three-month return +5.9%; RSI(14) 64.3.\n- The 2026-08-07 session was the reaction to the 2026-08-06 release. Third-party coverage put the intraday move at about -3.2% to roughly $35. A pre-print advance was sold into a beat, which is why RSI reads elevated on a stock nearly 30% below its high.\n- Published targets after the print, all dated 2026-08-07: Citigroup Neutral $36, Susquehanna Neutral $37, TD Cowen Buy $43 (raised from $42), JPMorgan Neutral $45, Needham Buy $45 (lowered). Every target sits above the close; three of the five ratings are Neutral, so the target migration is not a ratings cycle.\n- Crowding observables: no earnings date inside 30 days; the issuer is a net buyer of its own stock (~1.6M shares/~$50M in Q2) rather than an issuer into strength; no insider Form 4 activity in the current window; coverage is sell-side and institutional, with no retail-sentiment clustering visible in the news flow. Sentiment is not the constraint here — willingness to pay a higher multiple is.\n- Life-cycle: **MATURING**. The agentic-operations framework has been the stated strategy since the June 2025 strategy day and ATS has been a reported line for several quarters, so this is not fresh attention. It still works in the numbers — ATS +24.1%, thirteen quarters of margin expansion — while flow moderates: a beat plus a segment guidance raise produced a down day on 2026-08-07. Two more prints of ≥25% ATS growth with no multiple response would move the label toward DEAD.\n\n## Catalyst Calendar (next 30 days)\n- **~2026-08-12 (est.)** — Q2 FY26 Form 10-Q. Carries headcount, receivables and remaining repurchase authorization that the earnings summary does not.\n- **2026-09-10** — record date for the $0.1875/share Q3 dividend declared 2026-07-16 (payable 2026-09-24). The nearest hard corporate date; it resolves nothing about the thesis.\n- **~2026-09-25 (est.)** — Accenture fiscal Q4 results. Sector bookings read-through; Genpact's multiple has historically moved with the services complex rather than independently of it.\n- **~2026-11-05 (est.)** — Q3 FY26 print. The genuine binary: whether Core Business Services declines as guided, whether ATS holds ≥25%, and whether the ~2pp exit headwind lands as sized.\n\n## What Would Change Our Mind\nThe 73% is what breaks this. Core Business Services grew 1.9% to $980M in Q2 and was guided flat-to-slightly-down for Q3; management sized the full-year drag from exiting non-strategic work at roughly two points, concentrated in H2. If that segment prints an outright year-over-year decline at the Q3 report (~2026-11-05, est.) while ATS growth slips under 20%, the mix argument stops being a re-rate case and becomes a shrinking base with a fast-growing corner. A cut to the \"at least 7%\" full-year revenue growth frame would say the exits were larger than disclosed. On the tape, a weekly close below $32 erases the entire three-month advance and the shelf built around the Q2 release, leaving no structure between the price and the year's lows. In the other direction: sustained trade back through the $38–$40 area alongside a Q3 print with CBS stable and ATS at or above 25% would be the first evidence the market is paying for the pivot rather than discounting the legacy book.\n\n## Correlation Notes\n- Moves with the IT and business-process services complex — Accenture, Cognizant, Infosys, Wipro, EPAM. Accenture's fiscal Q4 (~2026-09-25, est.) is the sector's next dated sentiment event and typically resets peer multiples before Genpact reports.\n- Inverse in narrative to the AI-infrastructure trade: the premise that agents replace seats bids compute and compresses services multiples. Genpact's 28.5% drawdown from $47.99 is the visible form of that discount, and the ATS line is the direct rebuttal being tested each quarter.\n- FX matters at the margin: Q2 reported growth 7.1% versus 6.9% constant currency (2026-08-06 release). The India-weighted delivery cost base makes INR/USD a margin input, not just a translation effect.\n- Rate-sensitive on the balance sheet: $1.18B total debt against $517.4M cash at 2026-06-30, with capital returns running ahead of first-half operating cash flow.",
  "first_seen": "2026-07-30",
  "last_analyzed": "2026-08-08T07:54:43+00:00",
  "last_synthesized": "2026-08-08",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}